Silexion Therapeutics (SLXN) EPS (Diluted) (2023 - 2026)
Silexion Therapeutics (SLXN) EPS (Diluted) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.29 Bn | 132.43 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 61.87 Bn | 56.73 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 28.90 Bn | 10.51 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 0.15 |
| 10 | Silexion Therapeutics | 270,129.73 | -1.96 Mn | - | -5.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.17 |
| Mar 31, 2026 | -8.46 |
| Dec 31, 2025 | -33.18 |
| Sep 30, 2025 | -28.80 |
| Jun 30, 2025 | -43.19 |
| Mar 31, 2025 | -38.39 |
| Dec 31, 2024 | -420.05 |
| Sep 30, 2024 | -2,747.28 |
| Jun 30, 2024 | 7,913.98 |
| Mar 31, 2024 | -1,910.07 |
| Dec 31, 2023 | -2,255.03 |
| Sep 30, 2023 | -1,085.91 |
| Jun 30, 2023 | 8,839.57 |